ArticleACS pharmacology & translational science2020

Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor.

Paris Avgoustou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.